Metraipolis › archive › dc_962b43fc59c2

QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations — Europe PMC PMID:41204044

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41204044
DOI
10.1007/s10928-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-08T17:47:45.738Z
SHA-256 of the archived text
a2fc86c60f0fc450e95274264abf70a98daa08f8ff205cfc636d47cf42810991
Stable URL of this page
https://metraipolis.com/documento/dc_962b43fc59c2

How to cite

QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations — Europe PMC PMID:41204044 — Europe PMC (en), https://europepmc.org/article/MED/41204044 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_962b43fc59c2 (Metraipolis archive dc_962b43fc59c2, sha256 a2fc86c60f0fc450e95274264abf70a98daa08f8ff205cfc636d47cf42810991)
BibTeX
@misc{dc962b43fc59c2,
  title = {QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations — Europe PMC PMID:41204044},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41204044},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_962b43fc59c2; sha256 a2fc86c60f0fc450e95274264abf70a98daa08f8ff205cfc636d47cf42810991},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41204044. Agents can read the archived copy with the MCP tool read_document.